Search

everythinglearnresearchcommunity

for

Search:↓

Many patients experienced hair loss after COVID-19, with women affected more, starting on average 49 days post-infection.

Social media data can help track and predict COVID-19 symptoms and trends.

Icosapent ethyl may help treat long-lasting symptoms after COVID-19.

COVID-19 may lead to severe skin necrosis without clear underlying causes, as seen in a diabetic patient who required leg amputation.

COVID-19 can cause a type of hair loss that usually starts 3-6 months after the illness, and treatment includes stress reduction and hair care products like Minoxidil.

The authors maintain that shorter androgen receptor alleles may lead to milder COVID-19 by positively affecting the immune response, not due to changes in testosterone levels or activity.

PrEP doesn't increase STI risk in high-risk men, anti-androgen drugs may lower ICU admission for male COVID-19 patients, a 3-point injection is better for crow's feet, and the 'Geriatric-8' tool could help assess frailty in older skin cancer patients.

Men with male pattern baldness may be more at risk for severe COVID-19, and anti-androgen treatments could offer protection.

Convolvulus arvensis ethanolic extract can potentially promote hair growth and reduce hair loss.

Hidradenitis suppurativa is caused by genetic factors, inflammation, bacteria, hormones, and lifestyle factors like obesity and smoking.

Using fat stem cells and blood cell-rich plasma together improves healing in diabetic wounds by affecting cell signaling.

Hair loss doesn't affect COVID-19 severity.

Proactive monitoring and management are essential to maximize the benefits of Trastuzumab Deruxtecan while minimizing serious side effects.

Topical spironolactone may help treat ocular graft-versus-host disease with minimal side effects.

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.

Caraway, Chinese chives, and cassia may improve health and prevent diseases due to their nutrients and medicinal properties.

Hair loss greatly affects quality of life, and dermatologists are crucial for proper diagnosis and treatment.

COVID-19 may trigger or worsen rapid hair loss in alopecia areata.

Male cancer patients have a higher risk of severe illness and death from COVID-19 than female patients.

The pandemic changed how often certain skin conditions were diagnosed.

COVID-19 patients often have skin issues like chilblain-like lesions and rashes, which can help in early diagnosis and sometimes indicate severe illness.

More children are showing signs of hair-pulling disorders during the COVID-19 pandemic due to stress and lack of social interaction.

Epipharyngeal Abrasive Therapy helps reduce symptoms in Long COVID patients with chronic epipharyngitis.

Doctors should thoroughly inform hair transplant patients about the procedure, risks, and costs to prevent dissatisfaction and legal issues.

COVID-19 can cause various skin issues, including rashes and 'COVID toes', and may worsen autoimmune diseases or affect men with baldness more severely.

Acute telogen effluvium can be resolved by addressing causes, but chronic telogen effluvium is harder to treat.

Dietary supplements might help prevent post-COVID hair loss, but serum ferritin is not a reliable indicator.

Copper deficiency is linked to post-COVID-19 hair loss in women.

Plant-derived extracellular vesicles show promise for treating diseases like cancer and inflammation.

Many doctors lack knowledge about COVID-19 skin symptoms and need better education and guidelines.